通过 [实验技术 1，如：细胞表型分析、动物模型构建、组学测序等] 手段，系统观察目标生物学现象的特征与变化规律；

聚焦核心候选分子 / 细胞通路，利用 [实验技术 2，如：基因沉默 / 过表达、蛋白互作分析、信号通路检测等] 深入挖掘其内在调控机制；

借助 [实验技术 3，如：临床样本验证、多模型交叉实验等]，验证研究结论的普适性与临床转化价值。

Fig. 3

• Schematic diagram illustrating the methods used to collect GV oocytes from 3-week-old control and Hnrnpm cKO mice.
• Quantitative analysis of GV oocytes collected from 3-week-old control and Hnrnpm cKO mice. Two-sided Student's t-tests. Data are presented as mean ± SEM. n = 10. ns not significant.
• Representative images of GV oocytes derived from control and Hnrnpm cKO mice. Large dark cytoplasmic granules were observed in Hnrnpm cKO mice. Scale bar: 20 μm.
• Quantitative analysis of GV oocytes displaying abnormal cytoplasmic granules in control and Hnrnpm cKO mice. Two-sided Student's t-tests. Data are presented as mean ± SEM. n = 10. p < 0.0001.
• Representative transmission electron microscopy (TEM) images of GV oocytes from control and Hnrnpm cKO mice. Red arrowheads denote cell lattices, blue arrowheads highlight mitochondria, and yellow arrowheads indicate lipid droplets. Scale bars: 2 μm (left), 1 μm (right).
• Representative fluorescent images showing mitochondrial distribution (MitoTracker-labeled) in germinal vesicle (GV) oocytes from control and Hnrnpm cKO mice. White arrowheads indicate mitochondrial aggregates. Scale bars: 20 μm.
• Nile red staining, indicating the distribution of lipid droplets in control and Hnrnpm cKO mice. White arrowheads indicate lipid aggregates. Scale bars: 20 μm.

Fig. 4

• Representative image showing IVM progression of control and Hnrnpm cKO oocytes. Scale bars: 50 μm.
• Quantitative analysis of germinal vesicle breakdown (GVBD) rates in control and Hnrnpm cKO mice. Two-sided Student's t-tests. Data are presented as mean ± SEM. n = 5. ns not significant.
• Quantitative analysis of polar body extrusion (PBE) rates in cultured oocytes from control and Hnrnpm cKO mice. Two-sided Student's t-tests. Data are presented as mean ± SEM. n = 5. p < 0.0001.
• Immunofluorescence showing spindle assembly, chromosome alignment, and microtubule-organizing centers (MTOCs) of control and Hnrnpm cKO oocytes after 8 h of in vitro culture. Microtubules were labeled with α-Tubulin (green) and TPX2 (red). The MTOCs are marked with pericentrin (green). Chromosomes were counterstained with DAPI (blue). Scale bars: 10 μm.
• Quantitative assessment of meiotic abnormalities in control and Hnrnpm cKO oocytes. Two-sided Student's t-tests. Data are presented as mean ± SEM. n = 3. p < 0.0001.
• Representative images showing spindle assembly, chromosome alignment, and MTOCs in control and Hnrnpm cKO oocytes after 16 h of in vitro culture. Scale bars: 10 μm.
• Proportion of oocytes with meiotic defects after 16 h in vitro maturation. Two-sided Student's t-tests. Data are presented as mean ± SEM. n = 5. p < 0.0001.

Fig. 6

• The numbers and categories of annotated differential alternative splicing (AS) events detected in GV oocytes following Hnrnpm depletion.
• GO term analysis of differentially alternative splicing (AS) genes by Metascape.
• Diagrammatic representation of alternative splicing quantification methodology using percentage spliced in (PSI) values. The PSI (Percent Spliced In) represents the relative abundance of transcripts containing a specific exon or splice site.
• Sashimi plots illustrating differential alternative splicing events of cell lattice formation-associated genes (Khdc3 and Nlrp14) and meiotic maturation-related genes (Cenph and Zar1l). PCR validation of these candidate genes confirmed the splicing alterations in Hnrnpm cKO oocytes. Schematic of alternatively spliced exons. Bar plots display the percentage spliced in (PSI) values of control and Hnrnpm cKO oocytes, calculated as PSI = splice_in/(splice_in + splice_out). Two-sided Student's t-tests. Data are presented as mean ± SEM. n = 3. p = 0.0022 (Khdc3), 0.0012 (Nlrp14), 0.0001 (Cenph), 0.0002 (Zar1l).

Fig. 7

• Schematic illustration of the LACE-seq workflow used to profile hnRNPM-binding sites in GV oocytes.
• Heatmap visualization of the hnRNPM LACE-seq signal intensity across all identified peaks. Genomic regions are displayed as 6-kb windows centered on peak summits, with hierarchical clustering of similar binding patterns.
• Pie chart displaying the genomic distribution of hnRNPM-binding sites identified by LACE-seq. CDS, coding sequence; UTR, untranslated region
• RNA-binding motifs of hnRNPM were characterized using de novo motif analysis of LACE-seq peaks using HOMER.
• GO term enrichment analysis of hnRNPM-binding transcripts.
• Venn diagram showing the overlap between hnRNPM-binding genes and differential alternative splicing (AS) genes. The heatmap on the right displays the GO enrichment results for the overlapping genes. Metascape was used to perform GO term.
• Genome browser tracks showing LACE-seq binding peak distributions of cell lattice formation-associated genes (Khdc3 and Nlrp14) and meiotic maturation-related genes (Cenph). The purple and green tracks show hnRNPM binding profiles from LACE-seq performed on control and cKO oocytes, respectively.

① 超高特异性，精准捕获目标信号

abs580304 经过严格的抗原筛选与亲和纯化工艺，能特异性识别目标分子，有效规避同源蛋白交叉反应。在复杂临床样本（如组织提取物、体液样本）或细胞混合体系中，仍能精准捕获目标信号，避免假阳性结果干扰，确保分子表达检测的准确性。

② 高灵敏度，不放过低丰度信号

采用先进的标记技术与制备工艺，abs580304 检测下限低，可高效检测低丰度表达的目标分子。无论是早期疾病样本、微量细胞样本，还是干预后轻微表达变化的场景，都能精准量化信号差异，为机制研究提供灵敏的检测工具。

③ 稳定性卓越，批次间一致性高

严格遵循 ISO 质量控制标准，从原料采购到生产灌装全程无菌管控，批次间活性、浓度、特异性高度统一。研究中涉及的多批次实验、长期追踪检测等场景，均能保证数据可重复，大幅降低因试剂波动导致的实验误差。

④ 兼容性广泛，适配多实验体系

abs580304 可灵活适配 WB、IF、IHC、流式细胞术等多种实验技术，无需调整核心实验条件，能满足研究中多维度验证的需求。无论是分子水平定量、细胞水平定位，还是组织水平分布观察，都能稳定发挥作用，提升实验效率。

⑤ 即用型设计，简化实验流程

采用便捷的即用型配方，无需复杂的前期稀释、活化步骤，开瓶即可投入实验。既节省了实验准备时间，又降低了因操作不当导致的误差，尤其适配高通量样本检测与多组学联合分析场景。